Earnings Feed
Start Free
Home/Filings/4/0001735276-26-000011
4//SEC Filing

Fitzgerald Kevin Joseph 4

Accession 0001735276-26-000011

CIK 0001178670other
View on SEC.govCompany Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 4:21 PM ET

Size

55.0 KB

Accession

0001735276-26-000011

Insider Transaction Report

Form 4
Period: 2026-01-11
ALNYLAM PHARMACEUTICALS, INC.ALNY
Fitzgerald Kevin Joseph
CSO & EVP, Head of Research
Transactions
  • Award

    Common Stock

    [F1]
    2026-01-11+3,800→ 25,064 total
  • Sale

    Common Stock

    [F2][F3]
    2026-01-12$353.95/sh−39$13,804→ 25,025 total
  • Sale

    Common Stock

    [F2][F4]
    2026-01-12$355.16/sh−42$14,917→ 24,983 total
  • Sale

    Common Stock

    [F2][F5]
    2026-01-12$356.09/sh−41$14,600→ 24,942 total
  • Sale

    Common Stock

    [F2][F6]
    2026-01-12$357.17/sh−96$34,288→ 24,846 total
  • Sale

    Common Stock

    [F2][F7]
    2026-01-12$358.18/sh−123$44,056→ 24,723 total
  • Sale

    Common Stock

    [F2][F8]
    2026-01-12$359.14/sh−85$30,527→ 24,638 total
  • Sale

    Common Stock

    [F2][F9]
    2026-01-12$360.22/sh−155$55,834→ 24,483 total
  • Sale

    Common Stock

    [F2][F10]
    2026-01-12$361.45/sh−98$35,422→ 24,385 total
  • Sale

    Common Stock

    [F2][F11]
    2026-01-12$362.38/sh−73$26,454→ 24,312 total
  • Sale

    Common Stock

    [F2][F12]
    2026-01-12$363.55/sh−47$17,087→ 24,265 total
  • Sale

    Common Stock

    [F2][F13]
    2026-01-12$364.83/sh−199$72,601→ 24,066 total
  • Sale

    Common Stock

    [F2][F14]
    2026-01-12$365.56/sh−220$80,423→ 23,846 total
  • Sale

    Common Stock

    [F2][F15]
    2026-01-12$366.41/sh−50$18,321→ 23,796 total
  • Sale

    Common Stock

    [F2][F16]
    2026-01-12$367.40/sh−41$15,063→ 23,755 total
  • Sale

    Common Stock

    [F2][F17]
    2026-01-12$368.62/sh−92$33,913→ 23,663 total
  • Sale

    Common Stock

    [F2][F18]
    2026-01-12$369.48/sh−40$14,779→ 23,623 total
  • Sale

    Common Stock

    [F2][F19]
    2026-01-12$370.87/sh−19$7,047→ 23,604 total
  • Sale

    Common Stock

    [F2][F20]
    2026-01-12$372.46/sh−2$745→ 23,602 total
  • Sale

    Common Stock

    [F2][F21]
    2026-01-12$374.44/sh−14$5,242→ 23,588 total
  • Sale

    Common Stock

    [F2]
    2026-01-12$375.65/sh−19$7,137→ 23,569 total
  • Sale

    Common Stock

    [F2]
    2026-01-12$377.82/sh−15$5,667→ 23,554 total
  • Sale

    Common Stock

    [F22][F23]
    2026-01-13$367.52/sh−197$72,401→ 23,357 total
  • Sale

    Common Stock

    [F22][F24]
    2026-01-13$368.76/sh−562$207,243→ 22,795 total
  • Sale

    Common Stock

    [F22][F25]
    2026-01-13$370.00/sh−644$238,280→ 22,151 total
  • Sale

    Common Stock

    [F22][F26]
    2026-01-13$371.24/sh−485$180,051→ 21,666 total
  • Sale

    Common Stock

    [F22][F27]
    2026-01-13$372.93/sh−280$104,420→ 21,386 total
  • Sale

    Common Stock

    [F22][F28]
    2026-01-13$374.33/sh−122$45,668→ 21,264 total
Holdings

  • Common Stock

    [F29]
    (indirect: by Managed Account)
    537
Footnotes (29)
  • [F1]On March 1, 2024, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of forty (40) percent of the shares subject to the PSU based on the issuer publicly reporting $2.5 billion in annual net product revenue in accordance with GAAP, as determined by the People, Culture and Compensation Committee of the Issuer Board of Directors on January 11, 2026.
  • [F10]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $360.90 to $361.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F11]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $361.93 to $362.92. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F12]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $362.99 to $363.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F13]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $364.00 to $365.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F14]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $365.01 to $366.01. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F15]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $366.03 to $366.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F16]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $367.04 to $368.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F17]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $368.09 to $369.08. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F18]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $369.13 to $369.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F19]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $370.43 to $371.23. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F2]Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement to cover minimum statutory tax withholding obligations.
  • [F20]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $372.35 to $372.50. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F21]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $374.08 to $374.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F22]This transaction was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the Reporting Person on August 14, 2025.
  • [F23]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $367.18 to $367.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F24]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $368.25 to $369.23. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F25]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $369.36 to $370.35. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F26]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $370.52 to $371.47. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F27]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $372.70 to $373.11. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F28]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $374.28 to $374.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F29]Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.
  • [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $353.53 to $354.41. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $354.54 to $355.53. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.62 to $356.61. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $356.63 to $357.63. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F7]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $357.68 to $358.68. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F8]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $358.69 to $359.66. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F9]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $359.79 to $360.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald|2026-01-14

Documents

1 file

Issuer

ALNYLAM PHARMACEUTICALS, INC.

CIK 0001178670

→
Entity typeother

Related Parties

1
  • filerCIK 0001886431

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 4:21 PM ET
Size
55.0 KB
View on SEC.gov